Skip to main content
Erschienen in: Infection 5/2021

05.06.2021 | Original Paper

The emergence of Staphylococcus aureus as the primary cause of cardiac device-related infective endocarditis

verfasst von: Jean-Marie Urien, Christophe Camus, Christophe Leclercq, Loren Dejoies, Philippe Mabo, Raphael Martins, Sarrah Boukthir, François Bénézit, Nathalie Behar, Matthieu Revest, Sylvain Bodi, Julien Bila, Erwan Donal, Pierre Tattevin

Erschienen in: Infection | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Increasing use of cardiovascular implantable electronic devices (CIED), as permanent pacemakers (PPM), implantable cardioverter defibrillators (ICD), or cardiac resynchronization therapy (CRT), is associated with the emergence of CIED-related infective endocarditis (CIED-IE). We aimed to characterize CIED-IE profile, temporal trends, and prognostic factors.

Methods

CIED-IE diagnosed at Rennes University Hospital during years 1992–2017 were identified through computerized database, and included if they presented all of the following: (1) clinical signs of infection; (2) microbiological documentation through blood and/or CIED lead cultures; (3) lead or valve vegetation, or definite IE according to Duke criteria. Data were retrospectively extracted from medical charts. The cohort was categorized in three periods: 1992–1999, 2000–2008, and 2009–2017.

Results

We included 199 patients (51 women, 148 men, median age 73 years [interquartile range, 64–79]), with CIED-IE: 158 PPMs (79%), 24 ICD (12%), and 17 CRT (9%). Main pathogens were coagulase-negative staphylococci (CoNS: n = 86, 43%), Staphylococcus aureus (n = 60, 30%), and other Gram-positive cocci (n = 28, 14%). Temporal trends were remarkable for the decline in CoNS (P = 0.002), and the emergence of S. aureus as the primary cause of CIED-IE (24/63 in 2009–2017, 38%). Factors independently associated with one-year mortality were chronic obstructive pulmonary disease (COPD: hazard ratio 3.84 [1.03–6.02], P = 0.03), left-sided endocarditis (HR 2.25 [1.09–4.65], P = 0.03), pathogens other than CoNS (HR 3.16 [1.19–8.39], P = 0.02), and CIED removal/reimplantation (HR 0.41 [0.20–0.83], P = 0.01).

Conclusions

S. aureus has emerged as the primary cause of CIED-IE. Left-sided endocarditis, COPD, pathogens other than CoNS, and no CIED removal/reimplantation are independent risk factors for one-year mortality.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Sandoe JA, Barlow G, Chambers JB, Gammage M, Guleri A, Howard P, et al. Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE). J Antimicrob Chemother. 2015;70(2):325–59.CrossRef Sandoe JA, Barlow G, Chambers JB, Gammage M, Guleri A, Howard P, et al. Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE). J Antimicrob Chemother. 2015;70(2):325–59.CrossRef
2.
Zurück zum Zitat Kusumoto FM, Schoenfeld MH, Wilkoff BL, Berul CI, Birgersdotter-Green UM, Carrillo R, et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm. 2017;14:e503–51.CrossRef Kusumoto FM, Schoenfeld MH, Wilkoff BL, Berul CI, Birgersdotter-Green UM, Carrillo R, et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm. 2017;14:e503–51.CrossRef
3.
Zurück zum Zitat Loffler S, Kasper J, Postulka J, Cornak V, Bohunicky F, Zelenay J, et al. Septic complications in patients with permanent pacemakers. Cor Vasa. 1988;30:400–4.PubMed Loffler S, Kasper J, Postulka J, Cornak V, Bohunicky F, Zelenay J, et al. Septic complications in patients with permanent pacemakers. Cor Vasa. 1988;30:400–4.PubMed
4.
Zurück zum Zitat Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010;121:458–77.CrossRef Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010;121:458–77.CrossRef
5.
Zurück zum Zitat Cabell CH, Heidenreich PA, Chu VH, Moore CM, Stryjewski ME, Corey GR, et al. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990–1999. Am Heart J. 2004;147:582–6.CrossRef Cabell CH, Heidenreich PA, Chu VH, Moore CM, Stryjewski ME, Corey GR, et al. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990–1999. Am Heart J. 2004;147:582–6.CrossRef
6.
Zurück zum Zitat Deshmukh A, Patel N, Noseworthy PA, Patel AA, Patel N, Arora S, et al. Trends in use and adverse outcomes associated with transvenous lead removal in the United States. Circulation. 2015;132:2363–71.CrossRef Deshmukh A, Patel N, Noseworthy PA, Patel AA, Patel N, Arora S, et al. Trends in use and adverse outcomes associated with transvenous lead removal in the United States. Circulation. 2015;132:2363–71.CrossRef
7.
Zurück zum Zitat Sohail MR, Eby EL, Ryan MP, Gunnarsson C, Wright LA, Greenspon AJ. Incidence, treatment intensity, and incremental annual expenditures for patients experiencing a cardiac implantable electronic device infection: evidence from a large US payer database 1-year post implantation. Circ Arrhythm Electrophysiol. 2016;9(8):e003929.CrossRef Sohail MR, Eby EL, Ryan MP, Gunnarsson C, Wright LA, Greenspon AJ. Incidence, treatment intensity, and incremental annual expenditures for patients experiencing a cardiac implantable electronic device infection: evidence from a large US payer database 1-year post implantation. Circ Arrhythm Electrophysiol. 2016;9(8):e003929.CrossRef
8.
Zurück zum Zitat Murdoch DR, Corey GR, Hoen B, Miro JM, Fowler VG Jr, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169:463–73.CrossRef Murdoch DR, Corey GR, Hoen B, Miro JM, Fowler VG Jr, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169:463–73.CrossRef
9.
Zurück zum Zitat Selton-Suty C, Celard M, Le Moing V, Doco-Lecompte T, Chirouze C, Iung B, et al. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis. 2012;54:1230–9.CrossRef Selton-Suty C, Celard M, Le Moing V, Doco-Lecompte T, Chirouze C, Iung B, et al. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis. 2012;54:1230–9.CrossRef
10.
Zurück zum Zitat Tleyjeh IM, Abdel-Latif A, Rahbi H, Scott CG, Bailey KR, Steckelberg JM, et al. A systematic review of population-based studies of infective endocarditis. Chest. 2007;132:1025–35.CrossRef Tleyjeh IM, Abdel-Latif A, Rahbi H, Scott CG, Bailey KR, Steckelberg JM, et al. A systematic review of population-based studies of infective endocarditis. Chest. 2007;132:1025–35.CrossRef
11.
Zurück zum Zitat Gould PA, Gula LJ, Yee R, Skanes AC, Klein GJ, Krahn AD. Cardiovascular implantable electrophysiological device-related infections: a review. Curr Opin Cardiol. 2011;26:6–11.CrossRef Gould PA, Gula LJ, Yee R, Skanes AC, Klein GJ, Krahn AD. Cardiovascular implantable electrophysiological device-related infections: a review. Curr Opin Cardiol. 2011;26:6–11.CrossRef
12.
Zurück zum Zitat Athan E, Chu VH, Tattevin P, Selton-Suty C, Jones P, Naber C, et al. Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. JAMA. 2012;307:1727–35.CrossRef Athan E, Chu VH, Tattevin P, Selton-Suty C, Jones P, Naber C, et al. Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. JAMA. 2012;307:1727–35.CrossRef
13.
Zurück zum Zitat Cecchi E, Chirillo F, Castiglione A, Faggiano P, Cecconi M, Moreo A, et al. Clinical epidemiology in Italian Registry of Infective Endocarditis (RIEI): focus on age, intravascular devices and enterococci. Int J Cardiol. 2015;190:151–6.CrossRef Cecchi E, Chirillo F, Castiglione A, Faggiano P, Cecconi M, Moreo A, et al. Clinical epidemiology in Italian Registry of Infective Endocarditis (RIEI): focus on age, intravascular devices and enterococci. Int J Cardiol. 2015;190:151–6.CrossRef
14.
Zurück zum Zitat Kim DH, Tate J, Dresen WF, Papa FC Jr, Bloch KC, Kalams SA, et al. Cardiac implanted electronic device-related infective endocarditis: clinical features, management, and outcomes of 80 consecutive patients. Pacing Clin Electrophysiol. 2014;37:978–85.CrossRef Kim DH, Tate J, Dresen WF, Papa FC Jr, Bloch KC, Kalams SA, et al. Cardiac implanted electronic device-related infective endocarditis: clinical features, management, and outcomes of 80 consecutive patients. Pacing Clin Electrophysiol. 2014;37:978–85.CrossRef
15.
Zurück zum Zitat Greenspon AJ, Patel JD, Lau E, Ochoa JA, Frisch DR, Ho RT, et al. Trends in permanent pacemaker implantation in the United States from 1993 to 2009: increasing complexity of patients and procedures. J Am Coll Cardiol. 2012;60:1540–5.CrossRef Greenspon AJ, Patel JD, Lau E, Ochoa JA, Frisch DR, Ho RT, et al. Trends in permanent pacemaker implantation in the United States from 1993 to 2009: increasing complexity of patients and procedures. J Am Coll Cardiol. 2012;60:1540–5.CrossRef
16.
Zurück zum Zitat Greenspon AJ, Eby EL, Petrilla AA, Sohail MR. Treatment patterns, costs, and mortality among Medicare beneficiaries with cardiovascular implantable electronic devices infection. Pacing Clin Electrophysiol. 2018;41(5):495–503.CrossRef Greenspon AJ, Eby EL, Petrilla AA, Sohail MR. Treatment patterns, costs, and mortality among Medicare beneficiaries with cardiovascular implantable electronic devices infection. Pacing Clin Electrophysiol. 2018;41(5):495–503.CrossRef
17.
Zurück zum Zitat Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the european society of cardiology (ESC). endorsed by: european association for cardio-thoracic surgery (EACTS), the european association of nuclear medicine (EANM). Eur Heart J. 2015;36(44):3075–128.CrossRef Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the european society of cardiology (ESC). endorsed by: european association for cardio-thoracic surgery (EACTS), the european association of nuclear medicine (EANM). Eur Heart J. 2015;36(44):3075–128.CrossRef
18.
Zurück zum Zitat Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings Duke Endocarditis Service. Am J Med. 1994;96:200–9.CrossRef Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings Duke Endocarditis Service. Am J Med. 1994;96:200–9.CrossRef
19.
Zurück zum Zitat Dumont E, Camus C, Victor F, de Place C, Pavin D, Alonso C, et al. Suspected pacemaker or defibrillator transvenous lead infection. Prospective assessment of a TEE-guided therapeutic strategy. Eur Heart J. 2003;24(19):1779–87.CrossRef Dumont E, Camus C, Victor F, de Place C, Pavin D, Alonso C, et al. Suspected pacemaker or defibrillator transvenous lead infection. Prospective assessment of a TEE-guided therapeutic strategy. Eur Heart J. 2003;24(19):1779–87.CrossRef
20.
Zurück zum Zitat Osmonov D, Ozcan KS, Erdinler I, Altay S, Yildirim E, Turkkan C, et al. Cardiac device-related endocarditis: 31-Years’ experience. J Cardiol. 2013;61:175–80.CrossRef Osmonov D, Ozcan KS, Erdinler I, Altay S, Yildirim E, Turkkan C, et al. Cardiac device-related endocarditis: 31-Years’ experience. J Cardiol. 2013;61:175–80.CrossRef
21.
Zurück zum Zitat Welch M, Uslan DZ, Greenspon AJ, Sohail MR, Baddour LM, Blank E, et al. Variability in clinical features of early versus late cardiovascular implantable electronic device pocket infections. Pacing Clin Electrophysiol. 2014;37:955–62.CrossRef Welch M, Uslan DZ, Greenspon AJ, Sohail MR, Baddour LM, Blank E, et al. Variability in clinical features of early versus late cardiovascular implantable electronic device pocket infections. Pacing Clin Electrophysiol. 2014;37:955–62.CrossRef
22.
Zurück zum Zitat Victor F, De Place C, Camus C, Le Breton H, Leclercq C, Pavin D, et al. Pacemaker lead infection: echocardiographic features, management, and outcome. Heart. 1999;81:82–7.CrossRef Victor F, De Place C, Camus C, Le Breton H, Leclercq C, Pavin D, et al. Pacemaker lead infection: echocardiographic features, management, and outcome. Heart. 1999;81:82–7.CrossRef
23.
Zurück zum Zitat Fowler VG Jr, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA. 2005;293:3012–21.CrossRef Fowler VG Jr, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA. 2005;293:3012–21.CrossRef
24.
Zurück zum Zitat Baddour LM, Cha YM, Wilson WR. Clinical practice Infections of cardiovascular implantable electronic devices. N Engl J Med. 2012;367:842–9.CrossRef Baddour LM, Cha YM, Wilson WR. Clinical practice Infections of cardiovascular implantable electronic devices. N Engl J Med. 2012;367:842–9.CrossRef
25.
Zurück zum Zitat Jan E, Camou F, Texier-Maugein J, Whinnett Z, Caubet O, Ploux S, et al. Microbiologic characteristics and in vitro susceptibility to antimicrobials in a large population of patients with cardiovascular implantable electronic device infection. J Cardiovasc Electrophysiol. 2012;23:375–81.CrossRef Jan E, Camou F, Texier-Maugein J, Whinnett Z, Caubet O, Ploux S, et al. Microbiologic characteristics and in vitro susceptibility to antimicrobials in a large population of patients with cardiovascular implantable electronic device infection. J Cardiovasc Electrophysiol. 2012;23:375–81.CrossRef
26.
Zurück zum Zitat Ferraris L, Milazzo L, Rimoldi SG, Mazzali C, Barosi A, Gismondo MR, et al. Epidemiological trends of infective endocarditis in a single center in Italy between 2003–2015. Infect Dis (Lond). 2018;50(10):749–56.CrossRef Ferraris L, Milazzo L, Rimoldi SG, Mazzali C, Barosi A, Gismondo MR, et al. Epidemiological trends of infective endocarditis in a single center in Italy between 2003–2015. Infect Dis (Lond). 2018;50(10):749–56.CrossRef
27.
Zurück zum Zitat Rohacek M, Baddour LM. Cardiovascular implantable electronic device infections: associated risk factors and prevention. Swiss Med Wkly. 2015;145:w14157.PubMed Rohacek M, Baddour LM. Cardiovascular implantable electronic device infections: associated risk factors and prevention. Swiss Med Wkly. 2015;145:w14157.PubMed
28.
Zurück zum Zitat Gandhi T, Crawford T, Riddell J. Cardiovascular implantable electronic device associated infections. Infect Dis Clin North Am. 2012;26(1):57–76.CrossRef Gandhi T, Crawford T, Riddell J. Cardiovascular implantable electronic device associated infections. Infect Dis Clin North Am. 2012;26(1):57–76.CrossRef
29.
Zurück zum Zitat Le KY, Sohail MR, Friedman PA, Uslan DZ, Cha SS, Hayes DL, et al. Clinical features and outcomes of cardiovascular implantable electronic device infections due to staphylococcal species. Am J Cardiol. 2012;110:1143–9.CrossRef Le KY, Sohail MR, Friedman PA, Uslan DZ, Cha SS, Hayes DL, et al. Clinical features and outcomes of cardiovascular implantable electronic device infections due to staphylococcal species. Am J Cardiol. 2012;110:1143–9.CrossRef
30.
Zurück zum Zitat Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007;49:1851–9.CrossRef Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007;49:1851–9.CrossRef
31.
Zurück zum Zitat Greenspon AJ, Rhim ES, Mark G, Desimone J, Ho RT. Lead-associated endocarditis: the important role of methicillin-resistant Staphylococcus aureus. Pacing Clin Electrophysiol. 2008;31:548–53.CrossRef Greenspon AJ, Rhim ES, Mark G, Desimone J, Ho RT. Lead-associated endocarditis: the important role of methicillin-resistant Staphylococcus aureus. Pacing Clin Electrophysiol. 2008;31:548–53.CrossRef
32.
Zurück zum Zitat Smit J, Korup E, Schonheyder HC. Infections associated with permanent pacemakers and implanted cardioverter-defibrillator devices. A 10-year regional study in Denmark. Scand J Infect Dis. 2010;42(9):658–64.CrossRef Smit J, Korup E, Schonheyder HC. Infections associated with permanent pacemakers and implanted cardioverter-defibrillator devices. A 10-year regional study in Denmark. Scand J Infect Dis. 2010;42(9):658–64.CrossRef
33.
Zurück zum Zitat Viola GM, Awan LL, Ostrosky-Zeichner L, Chan W, Darouiche RO. Infections of cardiac implantable electronic devices: a retrospective multicenter observational study. Medicine (Baltimore). 2012;91:123–30.CrossRef Viola GM, Awan LL, Ostrosky-Zeichner L, Chan W, Darouiche RO. Infections of cardiac implantable electronic devices: a retrospective multicenter observational study. Medicine (Baltimore). 2012;91:123–30.CrossRef
34.
Zurück zum Zitat Uslan DZ, Gleva MJ, Warren DK, Mela T, Chung MK, Gottipaty V, et al. Cardiovascular implantable electronic device replacement infections and prevention: results from the REPLACE Registry. Pacing Clin Electrophysiol. 2012;35:81–7.CrossRef Uslan DZ, Gleva MJ, Warren DK, Mela T, Chung MK, Gottipaty V, et al. Cardiovascular implantable electronic device replacement infections and prevention: results from the REPLACE Registry. Pacing Clin Electrophysiol. 2012;35:81–7.CrossRef
35.
Zurück zum Zitat Baman TS, Gupta SK, Valle JA, Yamada E. Risk factors for mortality in patients with cardiac device-related infection. Circ Arrhythm Electrophysiol. 2009;2:129–34.CrossRef Baman TS, Gupta SK, Valle JA, Yamada E. Risk factors for mortality in patients with cardiac device-related infection. Circ Arrhythm Electrophysiol. 2009;2:129–34.CrossRef
36.
Zurück zum Zitat del Rio A, Anguera I, Miro JM, Mont L, Fowler VG Jr, Azqueta M, et al. Surgical treatment of pacemaker and defibrillator lead endocarditis: the impact of electrode lead extraction on outcome. Chest. 2003;124:1451–9.CrossRef del Rio A, Anguera I, Miro JM, Mont L, Fowler VG Jr, Azqueta M, et al. Surgical treatment of pacemaker and defibrillator lead endocarditis: the impact of electrode lead extraction on outcome. Chest. 2003;124:1451–9.CrossRef
37.
Zurück zum Zitat Massoure PL, Reuter S, Lafitte S, Laborderie J, Bordachard P, Clementy J, et al. Pacemaker endocarditis: clinical features and management of 60 consecutive cases. Pacing Clin Electrophysiol. 2007;30:12–9.PubMed Massoure PL, Reuter S, Lafitte S, Laborderie J, Bordachard P, Clementy J, et al. Pacemaker endocarditis: clinical features and management of 60 consecutive cases. Pacing Clin Electrophysiol. 2007;30:12–9.PubMed
38.
Zurück zum Zitat Baddour LM. Long-term suppressive antimicrobial therapy for intravascular device-related infections. Am J Med Sci. 2001;322:209–12.CrossRef Baddour LM. Long-term suppressive antimicrobial therapy for intravascular device-related infections. Am J Med Sci. 2001;322:209–12.CrossRef
39.
Zurück zum Zitat Sekiguchi Y. Conservative therapy for the management of cardiac implantable electronic device infection. J Arrhythm. 2016;32:293–6.CrossRef Sekiguchi Y. Conservative therapy for the management of cardiac implantable electronic device infection. J Arrhythm. 2016;32:293–6.CrossRef
40.
Zurück zum Zitat Deharo JC, Quatre A, Mancini J, Khairy P, Le Dolley Y, Casalta JP, et al. Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study. Heart. 2012;98:724–31.CrossRef Deharo JC, Quatre A, Mancini J, Khairy P, Le Dolley Y, Casalta JP, et al. Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study. Heart. 2012;98:724–31.CrossRef
Metadaten
Titel
The emergence of Staphylococcus aureus as the primary cause of cardiac device-related infective endocarditis
verfasst von
Jean-Marie Urien
Christophe Camus
Christophe Leclercq
Loren Dejoies
Philippe Mabo
Raphael Martins
Sarrah Boukthir
François Bénézit
Nathalie Behar
Matthieu Revest
Sylvain Bodi
Julien Bila
Erwan Donal
Pierre Tattevin
Publikationsdatum
05.06.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 5/2021
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-021-01634-5

Weitere Artikel der Ausgabe 5/2021

Infection 5/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.